Case 1 | Treating a long SFA lesion using Eluvia™ Drug Eluting stent
The patient was a 69-year-old male who presented with progressive, lifestyle limiting claudication affecting both lower extremities, with the right leg being more symptomatic.
"From Chronic > 200 mm occlusion to full inline flow- redefining what's possible with Eluvia in long complex SFA disease."
— Sonya S. Noor, M.D., FACS
Case 2 | Treating a highly calcified long SFA CTO with the SEISMIQ™ Intravascular Lithotripsy (IVL) System and Eluvia™ Drug-Eluting Vascular Stent System
A 71-year-old dialysis-dependent patient with diabetes and heavily calcified multilevel peripheral arterial disease presented with rapidly worsening rest pain and tissue loss from chronic limb-threatening ischemia—setting the stage for a highly complex revascularization case.
"Intravascular lithotripsy is entering its precision era. Building on years of calcium modification, Seismiq's design adds a new, transformative dimension to what IVL can do — selective, directional energy delivery tailored to the lesion and the patient. When paired with drug elution, this precision approach optimizes vessel preparation and supports the durable long-term outcomes our patients deserve. The following case demonstrates these capabilities in real-world practice."
— Liz Genovese, M.D., M.S., FACS